IDBS operates in the specialized intersection of scientific informatics and regulated cloud software for BioPharma companies. The stack—Java, React, Kubernetes, AWS, PostgreSQL—indicates a mature, containerized SaaS platform built for GxP compliance and scale. Hiring is heavily skewed toward marketing (14 roles) and support (11), with engineering (10) at roughly parity; paired with active projects in ABM, DACH expansion, and customer SaaS migration, this signals a post-product phase focused on go-to-market and regional expansion rather than core platform rebuilds.
IDBS develops cloud software for research and development, manufacturing, and regulatory workflows across the BioPharma product lifecycle. The company serves 80% of the top 20 global BioPharma companies through three main product lines: E-WorkBook (electronic laboratory notebook), Polar (cloud R&D data platform), and PIMS (manufacturing and process data management). IDBS is owned by Danaher and operates from Woking, Surrey, with 201–500 employees. The organization actively pursues geographic expansion and is scaling support operations alongside marketing-led customer acquisition efforts.
IDBS builds on Java, React, Kubernetes, and AWS. Database layer includes PostgreSQL, Oracle, and MongoDB. Deployment tooling includes Terraform, Docker, and Jenkins. Testing frameworks span JUnit, Jest, Mocha, Cypress, and Playwright.
Active projects include API strategy and event flow design, integration architecture with enterprise systems, customer SaaS migration, digital marketing automation, and regional field expansion in DACH and APAC regions. The company is also pursuing value-based selling and account-based marketing campaigns.
IDBS's technology stack, projects, and hiring signals are inferred from public hiring and company data — career pages, public listings, and company web presence — then clustered and de-duplicated. Figures are estimates that refresh over time. Read our full methodology →
This is not an official vendor or customer list. It is a technology-adoption signal inferred from public data, intended for B2B research.